Koenig & Bauer (SKB) investor relations material

Executive summary

• 9M revenue rose 0.7% YoY to €866.5m; order intake increased 16.4% to €997.3m and backlog reached €1,101.4m, its highest nine-month level since 2014.

• Q3 operating EBITDA was €19.6m, above H1’s €14.1m; 9M free cash flow was positive at €30.6m and FY2026 guidance was confirmed.

Financial highlights

• 9M revenue was €866.5m (+0.7%); Q3 revenue was €308.3m (-0.7% YoY), with sequential increases from Q1 to Q3.

• Gross profit rose 7.6% to €243.5m and gross margin improved to 28.1% from 26.3%.

• Operating EBITDA was €33.7m (-12.7%), with a 3.9% margin; Q3 operating EBITDA was €19.6m versus €26.9m a year earlier.

• Reported EBIT was -€6.2m, including €8.5m of non-operating extraordinary items; operating EBIT adjusted for these items was €2.3m. Net loss was €26.0m and EPS -€1.57.

• Reported 9M EBITDA was €25.2m, including €8.5m of non-operating extraordinary items, primarily related to the Albert-Frankenthal closure.

Outlook and guidance

• FY2026 revenue is expected at the prior-year level of €1,302.4m and operating EBITDA at ~€80m, subject to stable conditions.

• Guidance now uses operating EBITDA alongside revenue as the primary performance indicator, replacing operating EBIT.

• P&P is expected to deliver revenue at the prior-year level and slightly lower operating EBITDA; S&T is expected to deliver significantly higher revenue and earnings.

• Medium-term ambition: €1.5bn revenue and at least 8% operating EBITDA margin, excluding special effects such as drupa.